Birmingham Capital Management CO Inc/Al Organon & Co. Transaction History

Birmingham Capital Management CO Inc/Al

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Dec 13, 2023	BUY	$16.59 - $23.77 $128,406 - $183,979	7,740 Added 36.96%	28,681 $497,000
Q2 2023 Sep 19, 2023	SELL	$19.27 - $24.63 $71,009 - $90,761	-3,685 Reduced 14.96%	20,941 $435,000
Q4 2022 Mar 06, 2023	BUY	$23.31 - $28.61 $61,142 - $75,044	2,623 Added 11.92%	24,626 $688,000
Q3 2022 Dec 02, 2022	SELL	$23.4 - $34.25 $19,000 - $27,811	-812 Reduced 3.56%	22,003 $515,000
Q2 2022 Aug 30, 2022	SELL	$31.66 - $38.9 $30,393 - $37,344	-960 Reduced 4.04%	22,815 $770,000
Q1 2022 Apr 29, 2022	SELL	$30.45 - $39.36 $24,512 - $31,684	-805 Reduced 3.28%	23,775 $830,000
Q4 2021 Feb 11, 2022	BUY	$28.67 - $37.13 $325,605 - $421,685	11,357 Added 85.89%	24,580 $748,000
Q3 2021 Dec 20, 2021	BUY	$28.63 - $35.64 $94,135 - $117,184	3,288 Added 33.1%	13,223 $434,000
Q2 2021 Aug 02, 2021	BUY	$28.45 - $38.0 $282,650 - $377,530	9,935 New	9,935 $301,000

790

201M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.17B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Birmingham Capital Management CO Inc/Al, based on Form 13F filings with the SEC.

Stay updated on Birmingham Capital Management CO Inc/Al with notifications on news.